Skip to main content
All lobbying clients

GSK (FKA GLAXOSMITHKLINE INC.)

Lobbying client · District of Columbia · filed 2025 to 2026

$7,350,000 Reported spend
6 Filings counted
1 Firms hired
30 Bills named

Spend is reported income plus in-house expenses across 6 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (121722), not by name.

 Firms hired 1
 Bills named in these filings 30
  • HCONRES 14
    Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…
    6 filings
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    6 filings
  • HR 2214
    DRUG Act
    6 filings
  • HR 946
    ORPHAN Cures Act
    6 filings
  • S 1040
    Drug Competition Enhancement Act
    6 filings
  • S 1041
    Affordable Prescriptions for Patients Act
    6 filings
  • S 1095
    Stop STALLING Act
    6 filings
  • S 1096
    Preserve Access to Affordable Generics and Biosimilars Act
    6 filings
  • S 43
    Skinny Labels, Big Savings Act
    6 filings
  • S 832
    EPIC Act of 2025
    6 filings
  • S 864
    HELP Copays Act
    6 filings
  • S 891
    Bipartisan Health Care Act
    6 filings
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
    5 filings
  • HR 1574
    RESTORE Patent Rights Act of 2025
    5 filings
  • HR 3152
    Patent Eligibility Restoration Act of 2025
    5 filings
  • HR 3160
    PREVAIL Act
    5 filings
  • HR 3269
    ETHIC Act
    5 filings
  • HR 4121
    Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
    5 filings
  • HR 890
    Stopping Pharma’s Ripoffs and Drug Savings For All Act
    5 filings
  • S 1097
    Interagency Patent Coordination and Improvement Act of 2025
    5 filings
  • S 1414
    Expedited Access to Biosimilars Act
    5 filings
  • S 1546
    Patent Eligibility Restoration Act of 2025
    5 filings
  • S 1553
    PREVAIL Act
    5 filings
  • S 2256
    Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
    5 filings
  • S 652
    Protecting Patients from Deceptive Drug Ads Act
    5 filings
  • S 708
    RESTORE Patent Rights Act of 2025
    5 filings
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
    4 filings
  • HR 3944
    Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
    4 filings
  • HR 4213
    Department of Homeland Security Appropriations Act, 2026
    4 filings
  • HR 4570
    Interagency Patent Coordination and Improvement Act of 2025
    4 filings
 Reported by year 2 years
  • 2026 $2,530,000 2 filings
  • 2025 $4,820,000 4 filings
 Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 7
  • Centers For Medicare and Medicaid Services (CMS) 6
  • Health & Human Services, Dept of (HHS) 6
  • HOUSE OF REPRESENTATIVES 6
  • Office of Management & Budget (OMB) 6
  • Patent & Trademark Office (PTO) 6
  • SENATE 6
  • U.S. Trade Representative (USTR) 6

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem